[Therapy of bronchial asthma and asthma-like conditions].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D000336:Aerosols; D000741:Anemia, Aplastic / Q000139:chemically induced; D000962:Antimalarials / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000628:therapy*; D001945:Breathing Exercises; D002648:Child; D002701:Chloramphenicol / Q000009:adverse effects / Q000627:therapeutic use; D005100:Expectorants / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D026741:Physical Therapy Modalities; D011453:Prostaglandins / Q000627:therapeutic use; D011613:Psychotherapy; D013566:Sympathomimetics / Q000627:therapeutic use; D013806:Theophylline / Q000627:therapeutic use
D000336:Aerosols; D000962:Antimalarials; D005100:Expectorants; D007166:Immunosuppressive Agents; D011453:Prostaglandins; D013566:Sympathomimetics; D002701:Chloramphenicol; D000324:Adrenocorticotropic Hormone; D013806:Theophylline
Neue Aspekte zur Behandlung des Asthma bronchiale und asthmatiformer Zustände.